Published in Eur Heart J on January 22, 2007
Mutations in sodium channel β1- and β2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol (2009) 1.56
Arrhythmia pharmacogenomics: methodological considerations. Curr Pharm Des (2009) 0.76
Atrial arrhythmias in inherited arrhythmogenic disorders. J Arrhythm (2016) 0.75
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation (2005) 8.76
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm (2009) 4.99
Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med (2009) 4.53
Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation (2003) 3.68
FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77
Brugada syndrome: report of the second consensus conference. Heart Rhythm (2005) 2.48
Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol (2003) 2.44
Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol (2005) 2.39
Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome. Circulation (2011) 2.38
De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc Res (2005) 2.27
Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol (2012) 2.26
Traditional and nonlinear heart rate variability are each independently associated with mortality after myocardial infarction. J Cardiovasc Electrophysiol (2005) 2.25
Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet (2002) 2.16
Effect of opening a new catheterization laboratory on 30-day and 2-year survival rates in myocardial infarction patients. Rev Esp Cardiol (2011) 2.14
Familial pseudo-Wolff-Parkinson-White syndrome. J Cardiovasc Electrophysiol (2006) 2.11
Heart rate turbulence after ventricular and atrial premature beats in subjects without structural heart disease. J Cardiovasc Electrophysiol (2003) 2.03
Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Eur Heart J (2011) 1.99
The early repolarization pattern in the general population: clinical correlates and heritability. J Am Coll Cardiol (2011) 1.95
Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Circulation (2005) 1.94
Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation (2003) 1.92
Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J (2009) 1.92
Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. Heart Rhythm (2006) 1.91
Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation (2002) 1.91
Short QT syndrome: pharmacological treatment. J Am Coll Cardiol (2004) 1.87
Cryptic 5' splice site activation in SCN5A associated with Brugada syndrome. J Mol Cell Cardiol (2004) 1.81
Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation (2008) 1.81
Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol (2004) 1.80
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. Eur Heart J (2013) 1.77
Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol (2005) 1.74
Association of early repolarization and sudden cardiac death during an acute coronary event. Circ Arrhythm Electrophysiol (2012) 1.74
Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet (2013) 1.72
Electrophysiologic testing predicts events in Brugada syndrome patients. Heart Rhythm (2011) 1.70
Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:. J Cardiovasc Electrophysiol (2004) 1.69
Causes of nonischemic sudden cardiac death in the current era. Heart Rhythm (2011) 1.69
QRS-T angle as a predictor of sudden cardiac death in a middle-aged general population. Europace (2011) 1.68
Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol (2008) 1.67
Microvolt T-wave alternans during exercise and pacing in patients with acute myocardial infarction. Pacing Clin Electrophysiol (2005) 1.64
State of the art in forensic investigation of sudden cardiac death. Am J Forensic Med Pathol (2011) 1.61
Fractal analysis of heart rate variability and mortality after an acute myocardial infarction. Am J Cardiol (2002) 1.61
Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome. Heart Rhythm (2006) 1.56
Brugada syndrome: 1992-2002: a historical perspective. J Am Coll Cardiol (2003) 1.54
Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients. J Cardiovasc Electrophysiol (2007) 1.52
Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel. Circ Res (2011) 1.51
Physiological background of the loss of fractal heart rate dynamics. Circulation (2005) 1.51
The cloning, genomic organization and tissue expression profile of the human DLG5 gene. BMC Genomics (2002) 1.50
Heart rate turbulence after atrial premature beats before spontaneous onset of atrial fibrillation. J Am Coll Cardiol (2005) 1.49
Fever and Brugada syndrome. Pacing Clin Electrophysiol (2002) 1.48
Shocking truths about implantable cardioverter defibrillator monitoring zones. Pacing Clin Electrophysiol (2007) 1.48
Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace (2013) 1.47
The breakdown of fractal heart rate dynamics predicts prolonged postoperative myocardial ischemia. Anesth Analg (2004) 1.47
Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol (2011) 1.47
QRS-T morphology measured from exercise electrocardiogram as a predictor of cardiac mortality. Europace (2010) 1.47
Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J Am Coll Cardiol (2002) 1.46
Three genetic polymorphisms of homocysteine-metabolizing enzymes and risk of coronary heart disease: a meta-analysis based on 23 case-control studies. DNA Cell Biol (2011) 1.46
Comprehensive study of autonomic function in a population with primary Sjögren's syndrome. No evidence of autonomic involvement. J Rheumatol (2003) 1.44
KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders. Heart Rhythm (2009) 1.43
Prevalence and prognosis of ECG abnormalities in normotensive and hypertensive individuals. J Hypertens (2016) 1.41
Rebuttal to EP testing does not predict cardiac events in patients with Brugada syndrome. Heart Rhythm (2011) 1.39
Risk markers of late high-degree atrioventricular block in patients with left ventricular dysfunction after an acute myocardial infarction: a CARISMA substudy. Europace (2011) 1.39
Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet (2011) 1.38
Clinical impact of evaluation of cardiovascular control by novel methods of heart rate dynamics. Philos Trans A Math Phys Eng Sci (2009) 1.35
Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation (2006) 1.35
Exercise training improves baroreflex sensitivity in type 2 diabetes. Diabetes (2003) 1.33
Intraventricular conduction delay in a standard 12-lead electrocardiogram as a predictor of mortality in the general population. Circ Arrhythm Electrophysiol (2011) 1.31
Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res (2009) 1.28
Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation (2003) 1.21
Cardiovascular autonomic function correlates with the response to aerobic training in healthy sedentary subjects. Am J Physiol Heart Circ Physiol (2003) 1.20
Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J (2005) 1.20
Schizophrenia and sudden cardiac death: a review. Nord J Psychiatry (2008) 1.19
Short QT syndrome. CMAJ (2005) 1.17
Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation. J Hum Genet (2009) 1.17
Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy. Heart (2009) 1.15
Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation (2004) 1.14
Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome. Circ Arrhythm Electrophysiol (2009) 1.11
Brugada syndrome unmasked by pneumonia. Tex Heart Inst J (2006) 1.10
Genetic modulation of brugada syndrome by a common polymorphism. J Cardiovasc Electrophysiol (2009) 1.09
Brugada syndrome: from cell to bedside. Curr Probl Cardiol (2005) 1.08
Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome. Circulation (2006) 1.08
Clinical significance of variants of J-points and J-waves: early repolarization patterns and risk. Eur Heart J (2012) 1.07
Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment. Europace (2011) 1.07